Table 5.
Relative luciferase activity values for CAR1, CAR3 and PXR treated with group E compounds (Diphenyls).
CAR3 | CAR1 | PXR | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Control | PK11195 | Control | Rifampicin | ||||||||
ID | Chemical Name | Value | Siga | Value | Sig | Value | Sig | Value | Sig | Value | Sig |
0 | Solvent control | 1.00 | - | 1.00 | - | 0.76 | - | 1.00 | - | 2.35 | - |
E1 | 2-Benzylphenol | 0.79 | - | 0.93 | - | 0.66 | - | 1.13 | - | 2.50 | - |
E2 | 4-Benzylphenol | 0.80 | - | 1.02 | - | 0.83 | - | 1.14 | - | 2.42 | - |
E3 | Bis(4-hydroxyphenyl)methane | 1.69 | - | 1.06 | * | 0.83 | ** | 1.00 | - | 2.13 | - |
E4 | 4-Cumylphenol | 222.05 | *** | 1.03 | - | 0.76 | * | 2.04 | ** | 2.09 | - |
E5 | BPA [Bisphenol A] | 71.17 | *** | 1.10 | - | 0.87 | - | 1.68 | *** | 2.43 | - |
E6 | BPA dimethylether | 4.16 | *** | 1.15 | *** | 0.88 | - | 1.35 | *** | 2.17 | ** |
E7 | BPA diacetate | 381.41 | *** | 0.96 | ** | 0.71 | * | 1.51 | ** | 2.39 | - |
E8 | BADGE [BPA diglycidylether] | 0.88 | * | 0.81 | - | 0.81 | * | 1.39 | *** | 2.41 | - |
E9 | BPA dimethacrylate | 351.40 | *** | 1.31 | *** | 0.84 | - | 1.48 | ** | 2.49 | - |
E10 | Bisphenol Z [4,4′-Cyclohexylidenebisphenol] | 811.70 | *** | 1.39 | *** | 1.03 | *** | 2.25 | *** | 2.58 | - |
E11 | BPA, tetramethyl [4,4′-isoproplyidene bis(2,6-dimethylphenol)] | 9.97 | *** | 0.71 | *** | 0.80 | - | 2.29 | ** | 1.86 | * |
E12 | Bisphenol AF [4,4′-(Hexafluroisoproplyidene)diphenol] | 821.46 | *** | 1.33 | *** | 1.01 | *** | 1.20 | * | 1.77 | ** |
E13 | 4,4′-Dihydroxydiphenyl ether | 0.86 | - | 0.95 | - | 0.81 | - | 1.03 | - | 2.18 | - |
E14 | Bisphenol S [4,4′-Sulfonyldiphenol] | 2.09 | - | 1.01 | - | 0.77 | - | 0.69 | *** | 2.16 | - |
Sig = significance in unpaired t-test
Significant agonist effect
Significant inverse agonist/antagonist effect
0.01 < p < 0.05;
0.001 < p < 0.01;
p < 0.001